Koninklijke DSM NV (DSMN.AS)
91.96EUR
22 Feb 2019
€1.20 (+1.32%)
€90.76
€91.00
€92.58
€90.94
662,336
826,701
€96.38
€68.00
About
Overall
| Beta: | 0.83 |
| Market Cap(Mil.): | €12,599.97 |
| Shares Outstanding(Mil.): | 181.43 |
| Dividend: | 0.58 |
| Yield (%): | 2.56 |
Financials
| DSMN.AS | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 16.53 | 15.40 | 325.77 |
| EPS (TTM): | 4.20 | -- | -- |
| ROI: | 5.62 | 7.49 | 10.50 |
| ROE: | 13.12 | 11.78 | 13.69 |
DSM sets up vitamin E joint venture with China's Nenter
AMSTERDAM DSM NV, the Dutch nutrition company, said on Tuesday it would set up a joint venture with Chinese biochemicals company Nenter & Co. to manufacture vitamin E, paying Nenter 135 million euros ($154.45 million) to acquire its facilities in China.
DSM sets up vitamin E joint venture with China's Nenter
AMSTERDAM, Jan 29 DSM NV, the Dutch nutrition company, said on Tuesday it would set up a joint venture with Chinese biochemicals company Nenter & Co. to manufacture vitamin E, paying Nenter 135 million euros ($154.45 million) to acquire its facilities in China.
UPDATE 1-DSM Q3 core profit rises 11 pct on higher vitamin prices
AMSTERDAM, Oct 31 Dutch speciality chemicals company DSM on Wednesday beat analyst expectations with an 11-percent rise in third-quarter core profit, to 406 million euros ($460.4 million), helped by elevated vitamin prices and higher sales.
DSM Q3 core profit rises 11 pct on higher vitamin prices
AMSTERDAM, Oct 31 Dutch speciality chemicals company DSM on Wednesday beat analyst expectations with an 11-percent rise in third-quarter core profit, to 406 million euros ($460.4 million), helped by elevated vitamin prices and higher sales.
Estimates